| 前收市價 | 15.21 |
| 開市 | 15.30 |
| 買盤 | 15.21 x 200 |
| 賣出價 | 15.26 x 500 |
| 今日波幅 | 15.11 - 15.53 |
| 52 週波幅 | 15.11 - 33.99 |
| 成交量 | |
| 平均成交量 | 1,901,554 |
| 市值 | 2.52B |
| Beta 值 (5 年，每月) | 0.42 |
| 市盈率 (最近 12 個月) | ∞ |
| 每股盈利 (最近 12 個月) | 0.00 |
| 業績公佈日 | 2024年7月31日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 27.39 |
Insider MonkeyACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 […]
ZacksAcadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
Acadia (ACAD) delivered earnings and revenue surprises of 150% and 0.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksWatch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
